Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of different doses of remifentanil in PSV vs NAVA in mechanically ventilated ICU patients
2009-010366-28Phase 4Completed
- Sponsor
- Policlinico Gemelli
- Start
- Jun 2009
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of remifentanil in acute respiratory decompensation (2 arms), sponsored by Policlinico Gemelli. Primary endpoint: Patient-ventilator interaction and tolerance to mechanical ventilation. Started Jun 2009; status: completed.
02
Drugs
remifentanil
03
Conditions
acute respiratory decompensation
Beyond the preview
Go deeper on 2009-010366-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-010366-28.